Literature DB >> 14749721

Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter.

Inka Albrecht1, Thomas Tapmeier, Stefan Zimmermann, Markus Frey, Klaus Heeg, Alexander Dalpke.   

Abstract

Toll-like receptors (TLRs) mediate recognition of microbial components. Despite activation of a shared set of signal transduction molecules, the biological effects of certain TLR agonists differ considerably. In macrophages and dendritic cells, stimulation by the prototypical stimuli CpG-DNA (TLR9), lipopolysaccharide (LPS; TLR4) and lipoteichoic acid (LTA; TLR2) resulted in striking differences in expression of IL-12. However, these stimuli induced similar amounts of the common proinflammatory cytokine TNFalpha. Surprisingly, an IL-12p40 promoter reporter construct was activated equally by CpG-DNA, LPS and LTA. Examinations of the chromatin structure of the endogenous IL-12p40 promoter revealed that nucleosome remodelling contributed to differential IL-12 induction. Upon stimulation, nucleosome architecture was changed to provide increased access to the IL-12p40 promoter. In dendritic cells, a differential induction of nucleosome remodelling at the IL-12p40 promoter was observed upon triggering with different TLR agonists. These results identify nucleosome remodelling as an additional restriction point in differential TLR signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749721      PMCID: PMC1298989          DOI: 10.1038/sj.embor.7400078

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  21 in total

1.  Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription.

Authors:  A S Weinmann; S E Plevy; S T Smale
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene.

Authors:  S Rao; E Procko; M F Shannon
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

3.  Modifying gene expression programs by altering core promoter chromatin architecture.

Authors:  Stavros Lomvardas; Dimitris Thanos
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.

Authors:  Corinna Hermann; Ingo Spreitzer; Nicolas W J Schröder; Siegfried Morath; Martin D Lehner; Werner Fischer; Christine Schütt; Ralf R Schumann; Thomas Hartung
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

5.  Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators.

Authors:  M D Lehner; S Morath; K S Michelsen; R R Schumann; T Hartung
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event.

Authors:  A S Weinmann; D M Mitchell; S Sanjabi; M N Bradley; A Hoffmann; H C Liou; S T Smale
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

7.  Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2).

Authors:  C Becker; S Wirtz; X Ma; M Blessing; P R Galle; M F Neurath
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice.

Authors:  C A Salkowski; K Kopydlowski; J Blanco; M J Cody; R McNally; S N Vogel
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

9.  Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Authors:  Parviz Ahmad-Nejad; Hans Häcker; Mark Rutz; Stefan Bauer; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

10.  Two waves of nuclear factor kappaB recruitment to target promoters.

Authors:  S Saccani; S Pantano; G Natoli
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  14 in total

1.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

2.  Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance.

Authors:  Alexander H Dalpke; Martin D Lehner; Thomas Hartung; Klaus Heeg
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  IL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis.

Authors:  Taku Kobayashi; Katsuyoshi Matsuoka; Shehzad Z Sheikh; Steven M Russo; Yoshiyuki Mishima; Colm Collins; Edwin F deZoeten; Christopher L Karp; Jenny P Y Ting; R Balfour Sartor; Scott E Plevy
Journal:  J Immunol       Date:  2012-07-11       Impact factor: 5.422

4.  LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter.

Authors:  Stacey Garrett; Michael C Fitzgerald; Kathleen E Sullivan
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

5.  Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Noppadol Chaiyasit; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

6.  Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.

Authors:  Katsunori Yoshida; Guo-Xiang Yang; Weici Zhang; Masanobu Tsuda; Koichi Tsuneyama; Yuki Moritoki; Aftab A Ansari; Kazuichi Okazaki; Zhe-Xiong Lian; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

7.  Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Authors:  Konrad A Bode; Kate Schroder; David A Hume; Timothy Ravasi; Klaus Heeg; Matthew J Sweet; Alexander H Dalpke
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

8.  Bifidobacterium components have immunomodulatory characteristics dependent on the method of preparation.

Authors:  Yasuhiro Hiramatsu; Akira Hosono; Kyoko Takahashi; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2007-11-01       Impact factor: 2.058

9.  Systemically administered ligands of Toll-like receptor 2, -4, and -9 induce distinct inflammatory responses in the murine lung.

Authors:  H Ehrentraut; R Meyer; M Schwederski; S Ehrentraut; M Velten; C Grohé; P Knuefermann; G Baumgarten; O Boehm
Journal:  Mediators Inflamm       Date:  2011-03-22       Impact factor: 4.711

10.  Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression.

Authors:  Simon J Finney; Susannah K Leaver; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2011-12-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.